NCT00122616 arm group 90b30fd2e929a300ee75f0df5d26be6f [clinicaltrials_resource:NCT00122616/arm-group/90b30fd2e929a300ee75f0df5d26be6f]
NCT00122616 arm group 90b30fd2e929a300ee75f0df5d26be6f [clinicaltrials_resource:NCT00122616/arm-group/90b30fd2e929a300ee75f0df5d26be6f]
Bio2RDF identifier
NCT00122616/arm-group/90b30fd2e929a300ee75f0df5d26be6f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... b30fd2e929a300ee75f0df5d26be6f
description [clinicaltrials_vocabulary:description]
Day0 to week 96: HIV antiretroviral therapy
identifier
clinicaltrials_resource:NCT00122616/arm-group/90b30fd2e929a300ee75f0df5d26be6f
title
NCT00122616 arm group 90b30fd2e929a300ee75f0df5d26be6f
@en
type
label
NCT00122616 arm group 90b30fd2 ...... 30fd2e929a300ee75f0df5d26be6f]
@en